GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26231
Submission : 2012-07-13
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 26232
Submission : 2012-07-13
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 24464
Submission : 2010-12-17
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 35897
Submission : 2021-05-21
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 28836
Submission : 2014-11-07
Status : Active
Type : IV
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 3696
Submission : 1980-01-28
Status : Active
Type : IV
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 37535
Submission : 2022-11-30
Status : Active
Type : IV
Portfolio PDF
Product Web Link
Virtual Booth
Digital Content
Website
Corporate PDF
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 9822
Submission : 1992-08-14
Status : Inactive
Type : IV
FINISHED DOSAGE FORMULATIONS
Drug : K-TAB
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 18279
Country : US
Patented : No
Drug : FETZIMA
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 204168
Country : US
Patented : Yes
Drug : URSO FORTE
Dosage Form : TABLET; ORAL
Application Number : 20675
Country : US
Patented : No
Drug : URSO 250
Dosage Form : TABLET; ORAL
Application Number : 20675
Country : US
Patented : No
Drug : KADIAN
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 20616
Country : US
Patented : No
Drug : DILACOR XR
Dosage Form : CAPSULE, EXTENDED RELEASE; ORAL
Application Number : 20092
Country : US
Patented : No
ESTROGENS, CONJUGATED SYNTHETIC B
Drug : ENJUVIA
Dosage Form : TABLET; ORAL
Application Number : 21443
Country : US
Patented : No
Drug : SIROLIMUS
Dosage Form : TABLET; ORAL
Application Number : 201578
Country : US
Patented : No
Drug : METOPROLOL SUCCINATE
Dosage Form : TABLET, EXTENDED RELEASE; ORAL
Application Number : 78889
Country : US
Patented : No
Drug : ERRIN
Dosage Form : TABLET; ORAL-28
Application Number : 76225
Country : US
Patented : No
EXCIPIENTS BY APPLICATIONS
Application : Granulation
Excipient Details : Sustained Release, Taste Masking, Moisture Barrier, Binder in Wet Granulation
Pharmacopoeia Ref : USP/NF: Ethyl cellulose disper...
Technical Specs : Not Available
Ingredient(s) : Ethyl Cellulose
MARKET PLACE
Reply
21 Aug 2024
Reply
05 Sep 2022
Reply
29 Jun 2022
Reply
16 Oct 2018
REF. STANDARDS & IMPURITIES
Ethylcellulose
CAS Number : 9004-57-3
Quantity Per Vial : 100 mg
Sale Unit : 1
Order Code : Y0001633
Batch No : 1
Price (€) : 79
Storage : +5°C ± 3°C
LOOKING FOR A SUPPLIER?